In the News

Recent Coverage of HMS in the News
December 9, 2014

Researchers have been studying RNA viruses—Ebola among them—for several years, and had been working on this diagnostic tool for at least two years before this year’s outbreak. HMS Professor of Microbiology and Immunobiolgy Lee Gehrke’s lab at MIT is creating the tool. 

December 8, 2014

Watching too much television may lower your chances of survival after colon cancer, new research suggests. Andrew Chan, associate professor of medicine at Massachusetts General Hospital, is quoted. 

December 7, 2014

Research on the human genome is advancing at a tremendous pace, and the cost of genetic testing is falling just as quickly. But those signs of scientific progress also raise complicated ethical issues for doctors, researchers and patients. Robert Green, associate professor of medicine at Boston's Brigham and Women's Hospital, is quoted.

December 7, 2014

Ophthalmologists had been enthusiastically using Genetech’s cancer drug Avastin, which cost about $50 a dose, to treat a common eye disease in the elderly, wet macular degeneration. Then Genentech introduced Lucentis, a nearly equivalent drug that cost $2,000 a dose and was approved specifically to treat the disease. Now, a new federal database shows that many of the doctors who were the top billers for Lucentis were also among the highest-paid consultants for Genentech, earning thousands of dollars to help promote the new drug. Eric Campbell, professor of medicine at Massachusetts General Hospital, is quoted.

December 7, 2014

Sushrut Jang, instructor in medicine at Beth Israel Deaconess Medical Center, authored this feature about how doctors at Brigham and Women's are helping to treat cancer in the Middle East.

December 6, 2014

California’s initial efforts to move almost 500,000 low-income seniors and disabled people automatically into managed care has been rife with problems in its first six months, leading to widespread confusion, frustration and resistance. Prompted by the Affordable Care Act, the federal government is trying to streamline services and cut costs for the 9 million Americans who are enrolled in both Medicare and Medicaid. David Grabowksi, professor of health care policy, is quoted.

December 6, 2014

Two cancer immunotherapy drugs, nivolumab and Keytruda, proved remarkably effective against the blood cancer Hodgkin lymphoma in two small, separate studies. The studies add to growing evidence of the potential for enlisting the immune system in the fight against a wide range of tumors. Margaret Shipp, professor of medicine at the Dana Farber Cancer Institute, is a senior co-author of the nivolumab study.

December 5, 2014

Parents welcoming a new baby into their family are no longer content to count fingers and toes to assess their infant's state of health: In a recent research survey, nearly half said they would be "very" or "extremely" interested in having their newborn's genome sequenced, and fully a third more pronounced themselves "somewhat" interested. Robert Green, associate professor of medicine at Brigham and Women's Hospital, is the study's senior author. Alan Beggs, Sir Edwin and Lady Manton Professor of Pediatrics at Boston Children's Hospital, co-directs the BabySeq Project.


Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.


Tell us about your awards
Share news of your achievements with the larger HMS community,  click here.


Book Reviews
If you are a faculty member who has published a book recently, click here.